CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Change in Roche’s Board of Directors

Neutral
AI Analysis

Summary

Roche's Board of Directors approved the nomination of Dr. Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to Roche's Board at the Annual General Meeting scheduled for March 9, 2027.

Importance:2/10
Sentiment:
0.00
board_appointmentgovernanceleadership
Related Companies

Read the original article

Published by GlobeNewswire Pharma on September 23, 2026 5:00 AM

Read Original